Human cell adhesion protein AAMP-1 and uses thereof
AssigneeNational Institutes of Health
InventorsMarie E. Beckner, Henry C. Krutzsch, Lance A. Liotta
Life of this patent
Estimating the term…
Loading patent…
AssigneeNational Institutes of Health
InventorsMarie E. Beckner, Henry C. Krutzsch, Lance A. Liotta
Estimating the term…
The present invention relates, in general, to AAMP-1, and to a peptide derived from the amino-terminal region of AAMP, P189. In particular, the present invention relates to a DNA segment encoding AAMP-1, P189 or fragments thereof; polypeptides encoded by said DNA segment; recombinant DNA molecules containing the DNA segment; cells containing the recombinant DNA molecule; a method of producing a AAMP-1, and P189 polypeptide or fragments thereof; antibodies specific to AAMP-1; and a method of measuring the amount of AAMP-1 in a sample. The present invention further relates to methods of using AAMP, P189 or fragments thereof in promoting cell-cell or cell-substrate adhesion, wound healing in patients, prosthetic acceptance, concentrating heparin in tissues, and inhibiting metastases and invasion of malignant cells.
A substantially pure polypeptide comprising an amino acid sequence showing at least 90% sequence identity to SEQ ID NO. 7, or a fragment thereof, wherein the polypeptide or fragment is capable of binding to heparin.
A substantially pure polyepeptide comprising the amino acid sequence of SEQ ID NO. 7.
Dependencies are inferred from the claim text.